SLC3A2 and neoplasm: IGN523 acts as a multifunctional therapeutic antibody that not only obstructs tumor amino acid translocation but also facilitates NK cell recognition and recruitment by binding to and aggregating the CD98 antigen on the tumor cell membrane.